Multi-elemental analysis of serum and amyloid fibrils in familial amyloid polyneuropathy patients

References

• Araki S, Mawatari S, Ohta M, Nakajima A, Kuroiwa Y. Polyneuritic amyloidosis in a Japanese family. Arch Neurol 1968; 18: 593–602
   PubMed Web of Science ®Google Scholar
• Ando Y, Nakamura M, Araki S. Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol 2005; 62: 1057–1062
   PubMed Web of Science ®Google Scholar
• Ando Y, Ando E, Ohlsson P I, Olofsson A, Sandgren O, Suhr O, Terazaki H, Obayashi K, Lundgren E, Ando M, Negi A. Analysis of transthyretin amyloid fibrils from vitreous samples in familial amyloidotic polyneuropathy (Val30Met). Amyloid 1999; 6: 119–123
   PubMed Web of Science ®Google Scholar
• Haraoka K, Ando Y, Ando E, Sandgren O, Hirata A, Nakamura M, Terazaki H, Tajiri T, Tanoue Y, Sun X, Okabe H, Tanihara H. Amyloid deposition in ocular tissues of patients with familial amyloidotic polyneuropathy (FAP). Amyloid 2002; 9: 183–189
   PubMed Web of Science ®Google Scholar
• Schreiber G, Richardson S J. The evolution of gene expression, structure and function of transthyretin. Comp Biochem Physiol B Biochem Mol Biol 1997; 116: 137–160
   PubMed Web of Science ®Google Scholar
• Sousa M M, Saraiva M J. Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling. Prog Neurobiol 2003; 71: 385–400
   PubMed Web of Science ®Google Scholar
• Hou X, Aguilar M I, Small D H. Transthyretin and familial amyloidotic polyneuropathy. Recent progress in understanding the molecular mechanism of neurodegeneration. FEBS J 2007; 274: 1637–1650
   PubMed Web of Science ®Google Scholar
• Andersson K, Olofsson A, Nielsen E H, Svehag S E, Lundgren E. Only amyloidogenic intermediates of transthyretin induce apoptosis. Biochem Biophys Res Commun 2002; 294: 309–314
   PubMed Web of Science ®Google Scholar
• Ando Y, Nyhlin N, Suhr O, Holmgren G, Uchida K, el Sahly M, Yamashita T, Terasaki H, Nakamura M, Uchino M, Ando M. Oxidative stress is found in amyloid deposits in systemic amyloidosis. Biochem Biophys Res Commun 1997; 232: 497–502
   PubMed Web of Science ®Google Scholar
• Contestabile A. Oxidative stress in neurodegeneration: mechanisms and therapeutic perspectives. Curr Top Med Chem 2001; 1: 553–568
   PubMedGoogle Scholar
• Finefrock A E, Bush A I, Doraiswamy P M. Current status of metals as therapeutic targets in Alzheimer's disease. J Am Geriatr Soc 2003; 51: 1143–1148
   PubMed Web of Science ®Google Scholar
• Bush A I. Metals and neuroscience. Curr Opin Chem Biol 2000; 4: 184–191
   PubMed Web of Science ®Google Scholar
• Gaeta A, Hider R C. The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy. Br J Pharmacol 2005; 146: 1041–1059
   PubMed Web of Science ®Google Scholar
• Atwood C S, Moir R D, Huang X, Scarpa R C, Bacarra N M, Romano D M, Hartshorn M A, Tanzi R E, Bush A I. Dramatic aggregation of Alzheimer Abeta by Cu(II) is induced by conditions representing physiological acidosis. J Biol Chem 1998; 273: 12817–12826
   PubMed Web of Science ®Google Scholar
• Miura T, Suzuki K, Kohata N, Takeuchi H. Metal binding modes of Alzheimer's amyloid beta-peptide in insoluble aggregates and soluble complexes. Biochemistry 2000; 39: 7024–7031
   PubMed Web of Science ®Google Scholar
• Castellani R J, Moreira P I, Liu G, Dobson J, Perry G, Smith M A, Zhu X. Iron: The redox-active center of oxidative stress in Alzheimer disease. Neurochem Res 2007; 32: 1640–1645
   PubMed Web of Science ®Google Scholar
• Jobling M F, Huang X, Stewart L R, Barnham K J, Curtain C, Volitakis I, Perugini M, White A R, Cherny R A, Masters C L, Barrow C J, Collins S J, Bush A I, Cappai R. Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106–126. Biochemistry 2001; 40: 8073–8084
   PubMed Web of Science ®Google Scholar
• Thackray A M, Knight R, Haswell S J, Bujdoso R, Brown D R. Metal imbalance and compromised antioxidant function are early changes in prion disease. Biochem J 2002; 362: 253–258
   PubMed Web of Science ®Google Scholar
• Forte G, Bocca B, Senofonte O, Petrucci F, Brusa L, Stanzione P, Zannino S, Violante N, Alimonti A, Sancesario G. Trace and major elements in whole blood, serum, cerebrospinal fluid and urine of patients with Parkinson's disease. J Neural Transm 2004; 111: 1031–1040
   PubMed Web of Science ®Google Scholar
• Bomboi G, Marchione F, Sepe-Monti M, De Carolis A, Bianchi V, Medda E, Pino A, Bocca B, Forte G, D'Ippolito C, Giubilei F. Correlation between metal ions and clinical findings in subjects affected by Alzheimer's disease. Ann Ist Super Sanita 2005; 41: 205–212
   Google Scholar
• Forte G, Alimonti A, Pino A, Stanzione P, Brescianini S, Brusa L, Sancesario G, Violante N, Bocca B. Metals and oxidative stress in patients with Parkinson's disease. Ann Ist Super Sanita 2005; 41: 891–195
   Google Scholar
• Bocca B, Forte G, Petrucci F, Pino A, Marchione F, Bomboi G, Senofonte O, Giubilei F, Alimonti A. Monitoring of chemical elements and oxidative damage in patients affected by Alzheimer's disease. Ann Ist Super Sanita 2005; 41: 197–203
   PubMedGoogle Scholar
• Exley C. Aluminium and iron, but neither copper nor zinc, are key to the precipitation of beta-sheets of Ab42 in senile plaque cores in Alzheimer's disease. J Alzheimers Dis 2006; 10: 173–177
   PubMed Web of Science ®Google Scholar
• Sato T, Ando Y, Susuki S, Mikami F, Ikemizu S, Nakamura M, Suhr O, Anraku M, Kai T, Suico M A, Shuto T, Mizuguchi M, Yamagata Y, Kai H. Chromium(III) ion and thyroxine cooperate to stabilize the transthyretin tetramer and suppress in vitro amyloid fibril formation. FEBS Lett 2006; 580: 491–491
   Google Scholar
• Goulle J P, Mahieu L, Castermant J, Neveu N, Bonneau L, Laine G, Bouige D, Lacroix C. Metal and metalloid multi-elementary ICP-MS validation in whole blood, plasma, urine and hair. Reference values. Forensic Sci Int 2005; 153: 39–44
   PubMed Web of Science ®Google Scholar
• Bocca B, Forte G, Petrucci F, Senofonte O, Violante N, Alimonti A. Development of methods for the quantification of essential and toxic elements in human biomonitoring. Ann Ist Super Sanita 2005; 41: 165–170
   PubMedGoogle Scholar
• Ueda M, Ando Y, Haraoka K, Katsuragi S, Terasaki Y, Sugimoto M, Sun X, Uchino M. Aging and transthyretin-related amyloidosis: pathologic examinations in pulmonary amyloidosis. Amyloid 2006; 13: 24–30
   PubMed Web of Science ®Google Scholar
• Ando Y, Terazaki H, Nakamura M, Ando E, Haraoka K, Yamashita T, Ueda M, Okabe H, Sasaki Y, Tanihara H, Uchino M, Inomata Y. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation. Transplantation 2004; 77: 345–349
   PubMed Web of Science ®Google Scholar
• Thylen C, Wahlqvist J, Haettner E, Sandgren O, Holmgren G, Lundgren E. Modifications of transthyretin in amyloid fibrils: analysis of amyloid from homozygous and heterozygous individuals with the Met30 mutation. Embo J 1993; 12: 743–748
   PubMed Web of Science ®Google Scholar
• FDA. Guidance for Industries. Bioanalytical Method Validation, US Department of Health and Human Services Food and Drug Administration. May 2001. CDER, Rockville, MD 2001
   Google Scholar
• Maynard C J, Bush A I, Masters C L, Cappai R, Li Q X. Metals and amyloid-beta in Alzheimer's disease. Int J Exp Pathol 2005; 86: 147–159
   PubMed Web of Science ®Google Scholar
• Moreira P I, Siedlak S L, Aliev G, Zhu X, Cash A D, Smith M A, Perry G. Oxidative stress mechanisms and potential therapeutics in Alzheimer disease. J Neural Transm 2005; 112: 921–932
   Google Scholar
• Lynch T, Cherny R A, Bush A I. Oxidative processes in Alzheimer's disease: the role of Abeta-metal interactions. Exp Gerontol 2000; 35: 445–451
   Google Scholar
• Weaver J, Porasuphatana S, Tsai P, Cao G L, Budzichowski T A, Roman L J, Rosen G M. The effect of divalent cations on neuronal nitric oxide synthase activity. Toxicol Sci 2004; 81: 325–331
   Google Scholar
• Sousa M M, Du Yan S, Fernandes R, Guimaraes A, Stern D, Saraiva M J. Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways. J Neurosci 2001; 21: 7576–7586
   PubMed Web of Science ®Google Scholar